Reshma Kewalramani Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Reshma Kewalramani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Reshma Kewalramani for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 239.13 | 111 | 26,543 | 26,626 | 26.7 K to 26.6 K (-0.42 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 238.28 | 420 | 100,078 | 26,737 | 27.2 K to 26.7 K (-1.55 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 236.71 | 320 | 75,747 | 27,157 | 27.5 K to 27.2 K (-1.16 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 235.36 | 340 | 80,022 | 27,477 | 27.8 K to 27.5 K (-1.22 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 234.41 | 660 | 154,711 | 27,817 | 28.5 K to 27.8 K (-2.32 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 232.35 | 440 | 102,234 | 28,477 | 28.9 K to 28.5 K (-1.52 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 230.88 | 450 | 103,896 | 28,917 | 29.4 K to 28.9 K (-1.53 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 229.72 | 893 | 205,140 | 29,367 | 30.3 K to 29.4 K (-2.95 %) |
| Feb 26 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Payment of Exercise | F | 239.23 | 2,898 | 693,289 | 30,260 | 33.2 K to 30.3 K (-8.74 %) |
| Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 245.75 | 129 | 31,702 | 33,158 | 33.3 K to 33.2 K (-0.39 %) |
| Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 244.94 | 260 | 63,684 | 33,287 | 33.5 K to 33.3 K (-0.78 %) |
| Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 243.76 | 134 | 32,664 | 33,547 | 33.7 K to 33.5 K (-0.40 %) |
| Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 242.62 | 540 | 131,015 | 33,681 | 34.2 K to 33.7 K (-1.58 %) |
| Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 241.71 | 120 | 29,005 | 34,221 | 34.3 K to 34.2 K (-0.35 %) |
| Feb 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Payment of Exercise | F | 241.50 | 944 | 227,976 | 34,341 | 35.3 K to 34.3 K (-2.68 %) |